Safety and Efficacy of Arimoclomol in Patients With Inclusion Body Myositis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Lancet Neurol 2023 Oct 01;22(10)900-911, PM Machado, MP McDermott, T Blaettler, C Sundgreen, AA Amato, E Ciafaloni, M Freimer, SB Gibson, SM Jones, TD Levine, TE Lloyd, T Mozaffar, AI Shaibani, M Wicklund, A Rosholm, TD Carstensen, K Bonefeld, AN Jørgensen, K Phonekeo, AJ Heim, L Herbelin, RJ Barohn, MG Hanna, MM DimachkieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.